Google Übersetzer
Tenax Therapeutics, Inc.
About
11.88USD-0.10 -0.83%
Closed • Updated at 10:43 GMT+00:00Market Cap$315.12M
Volume497.6K
Beta-0.42
RSI42.39
Tenax Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 12 2026
Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 8 2026
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 4 2026
Tenax Therapeutics Appoints Timothy Healey, MBA as Chief Commercial Officer
Apr 22 2026
Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
Mar 10 2026
Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Recent Videos
Tenax P3: 75% FDA chance — possible $1.5–2B buyout.. massive asymmetric upside potential. TENX
May 07, 2026
TENX STOCK : PRICE EXPANSION | TENAX THERAPEUTICS STOCK
Apr 14, 2026
Why Tenax's $300M Shelf Is Not Desperation.. prudent positioning for massive growth TENX
Apr 08, 2026
Why Tenax Could Become a Multi Billion-Dollar Company in a few years TENX
Apr 08, 2026
Community Chat
Ask AI
Try asking